InsiderClue
Insiders · Profile

Hoitt Jason

Chief Patient Officer at Stoke Therapeutics. Filing since 17 Mar 2026. CIK 0001762572

Company
Date
Role
Action
Shares
Amount
Of holding
STOK Stoke Therapeutics, Inc.
18 Mar 2026
Chief Patient Officer
Sold at will
1,931
$60.53K
15.8%
STOK Stoke Therapeutics, Inc.
17 Mar 2026
Chief Patient Officer
Sold at will
1,781
$58.78K
12.7%
2 decisions on file.